1. Home
  2. RNXT vs DTST Comparison

RNXT vs DTST Comparison

Compare RNXT & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • DTST
  • Stock Information
  • Founded
  • RNXT 2012
  • DTST 2001
  • Country
  • RNXT United States
  • DTST United States
  • Employees
  • RNXT N/A
  • DTST N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • DTST EDP Services
  • Sector
  • RNXT Health Care
  • DTST Technology
  • Exchange
  • RNXT Nasdaq
  • DTST Nasdaq
  • Market Cap
  • RNXT 34.0M
  • DTST 23.7M
  • IPO Year
  • RNXT 2021
  • DTST N/A
  • Fundamental
  • Price
  • RNXT $0.91
  • DTST $3.44
  • Analyst Decision
  • RNXT Strong Buy
  • DTST
  • Analyst Count
  • RNXT 2
  • DTST 0
  • Target Price
  • RNXT $6.00
  • DTST N/A
  • AVG Volume (30 Days)
  • RNXT 69.8K
  • DTST 24.8K
  • Earning Date
  • RNXT 05-09-2025
  • DTST 03-31-2025
  • Dividend Yield
  • RNXT N/A
  • DTST N/A
  • EPS Growth
  • RNXT N/A
  • DTST 40.00
  • EPS
  • RNXT N/A
  • DTST 0.07
  • Revenue
  • RNXT $43,000.00
  • DTST $25,371,303.00
  • Revenue This Year
  • RNXT $690.69
  • DTST $2.57
  • Revenue Next Year
  • RNXT $4,006.81
  • DTST $11.16
  • P/E Ratio
  • RNXT N/A
  • DTST $51.14
  • Revenue Growth
  • RNXT N/A
  • DTST 1.65
  • 52 Week Low
  • RNXT $0.77
  • DTST $3.24
  • 52 Week High
  • RNXT $1.69
  • DTST $8.00
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 38.90
  • DTST 40.24
  • Support Level
  • RNXT $0.97
  • DTST $3.41
  • Resistance Level
  • RNXT $1.01
  • DTST $3.83
  • Average True Range (ATR)
  • RNXT 0.08
  • DTST 0.22
  • MACD
  • RNXT 0.00
  • DTST 0.01
  • Stochastic Oscillator
  • RNXT 34.72
  • DTST 25.71

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About DTST Data Storage Corporation

Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; Flagship Solutions, LLC and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.

Share on Social Networks: